Autobahn Therapeutics’ $100 Million Series C Round

Leila Ahmed North America Legal Chronicle
Tagged:

Wilson Sonsini Goodrich & Rosati advised Autobahn Therapeutics on the transaction.Autobahn Therapeutics, a biotechnology company, announced the closing of an oversubscribed $100 million Series C financing…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here